Medpace Holdings Inc (NASDAQ:MEDP)
| 240.64 Delayed Data As of Sep 21 |  -14.06 / -5.52%Today’s Change | 141.30 Today|||52-Week Range 282.73 | +13.29% Year-to-Date |
| SECTOR Commercial Services | INDUSTRY Miscellaneous Commercial Services | MARKET CAP $8.6B |
Company Description
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Contact Information
Medpace Holdings, Inc. 5375 Medpace Way Cincinnati Ohio 45227 |
Employees
Shareholders
| Mutual fund holders | 41.86% |
| Individual stakeholders | 39.29% |
| Other institutional | 38.45% |
Top Executives
| August James Troendle | Chairman & Chief Executive Officer |
| Jesse J. Geiger | President |
| Susan E. Burwig | Executive Vice President-Operations |
| Kevin M. Brady | Chief Financial Officer & Treasurer |
| Brandon Ebken | Chief Information Officer |
